Atrial fibrillation and congestive heart failure

Noel G Boyle1, Kalyanam Shivkumar

  • 1UCLA Cardiac Arrhythmia Center, Division of Cardiology, Department of Medicine, BH 407 CHS, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA. nboyle@mednet.ucla.edu

Insights

Atrial fibrillation (AF) and congestive heart failure (CHF) often coexist, complicating patient care. Newer therapies like biventricular pacing and radiofrequency ablation offer improved management strategies for these complex cardiac conditions.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology

Background:

  • Atrial fibrillation (AF) and congestive heart failure (CHF) are prevalent cardiac conditions with significant comorbidity.
  • The coexistence of AF and CHF exacerbates morbidity and mortality.
  • Managing AF in CHF patients is challenging due to heightened risks associated with antiarrhythmic drug therapy.

Purpose of the Study:

  • To review current treatment options for AF in patients with CHF.
  • To assess the efficacy of novel therapies, including biventricular pacing for CHF and radiofrequency ablation for AF.
  • To discuss findings from the AF-CHF study.

Main Methods:

  • Literature review of existing treatment modalities for AF in CHF.
  • Assessment of emerging therapies such as biventricular pacing and radiofrequency ablation.
  • Analysis of data from the AF-CHF study (reported November 2007).

Main Results:

  • The complex interplay between AF and CHF necessitates careful management.
  • Antiarrhythmic drug therapy poses increased risks in patients with both conditions.
  • Biventricular pacing and radiofrequency ablation represent newer therapeutic avenues.

Conclusions:

  • Effective management of coexisting AF and CHF requires tailored strategies.
  • Novel therapies show promise in improving outcomes for patients with both conditions.
  • Further research and clinical evaluation are ongoing for these complex cardiac comorbidities.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...